Showing results (181-190 of 360) with videos related to

Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|March 14, 2007
ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survivalPierre I Karakiewicz, Quoc-Dien Trinh, Alexandre de la Taille, et al.
Oncogene|November 7, 2002
The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cellsMin-Wei Chen, Francis Vacherot, Alexandre De La Taille, et al.
Urologia Internationalis|May 13, 2003
Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancerLaurent Salomon, Aristotelis G Anastasiadis, Patrick Antiphon, et al.
Urology|February 25, 2003
Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancerLaurent Salomon, Aristotelis G Anastasiadis, Olivier Levrel, et al.
International Journal of Molecular Sciences|November 13, 2021
Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial PeptideMickael Couty, Marie Dusaud, Mickael Miro-Padovani, et al.
Cancers|August 12, 2022
Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder CancerElliott Diamant, Mathieu Roumiguié, Alexandre Ingels, et al.
Journal of Sex & Marital Therapy|April 4, 2002
Sexual dysfunction is common and overlooked in female patients with hypertensionMartin Burchardt, Tatjana Burchardt, Aristotelis G Anastasiadis, et al.
Cancer|January 31, 2007
Prognostic ability of simplified nuclear grading of renal cell carcinomaNathalie Rioux-Leclercq, Pierre I Karakiewicz, Quoc-Dien Trinh, et al.
The International Journal of Biological Markers|June 15, 2010
Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinomaBernard Paule, Emmanuelle Deslandes, St Phane E Le Mouel, et al.
The Prostate|April 4, 2017
External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patientsJean-Baptiste Beauval, Bastien Cabarrou, Giorgio Gandaglia, et al.
Pageof 36